241. PK/PD Studies: Saturday, 12:15 - 1:30 p.m.
Poster Session: PK/PD Studies
Kajal Larson, PhD (she/her/hers)
Director, Clinical Pharmacology
Innoviva Specialty Therapeutics
Waltham, Massachusetts, United States
Sujata M. Bhavnani, PharmD; MS; FIDSA
Executive Vice President
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
Jeffrey P. Hammel, MS
Director
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
Anthony P. Cammarata, M.S.
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
John O'Donnell, B.S
Head of DMPK
Entasis Therapeutics
Waltham, Massachusetts, United States
Christopher M. Rubino, PharmD
Executive Vice President
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States